Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 |
filingDate |
2005-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008512355-A |
titleOfInvention |
Immunoglobulin containing predominantly GlcNAcMan5Man3GlcNAc2 glycoform |
abstract |
The present invention relates to an immunoglobulin glycoprotein composition having the predominant glycoform structure of an immunoglobulin glycoprotein that confers specific effector functions. In addition, the present invention relates to a pharmaceutical composition comprising an antibody having a specific enriched N-glycan structure, wherein the N-glycan structure is GlcNAcMan 5 GlcNAc 2 . |
priorityDate |
2004-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |